Finasteride Cost in West Virginia 2026

What Does Finasteride Actually Cost in West Virginia Right Now?

Generic finasteride 1 mg tablets cost about $12 per month at West Virginia retail pharmacies in 2026 when paid with cash or a free discount card. That price dropped sharply after generic competition entered the market following Merck's patent expiration. Brand-name Propecia carries a manufacturer list price of roughly $85 per month, but almost no cash-paying patient needs to pay that figure.

The generic-to-brand gap exists because finasteride is a small-molecule drug that multiple manufacturers now produce. Major pharmacy chains in Morgantown, Charleston, Huntington, and Parkersburg all stock the generic. GoodRx, RxSaver, and similar platforms typically show $9 to $15 for a 30-count supply of 1 mg tablets at WV locations. Walgreens, CVS, and Kroger pharmacies each participate in at least one free discount program. A 90-day supply often drops the per-tablet cost further, bringing some WV patients to roughly $0.30 per tablet. Finasteride's pharmacology and clinical efficacy are reviewed on the FDA's prescribing information page.

Compounded finasteride from a licensed West Virginia 503A pharmacy costs closer to $45 per month. That price typically includes a clinician review fee bundled by the dispensing pharmacy or telehealth platform, so the out-of-pocket comparison against $12 generic tablets is not perfectly apples-to-apples. The clinical rationale for compounding (for example, combining finasteride with minoxidil in a single topical or oral formulation) may justify the higher price for some patients.

Finasteride 5 mg tablets for benign prostatic hyperplasia (BPH), sold under the brand name Proscar, follow a similar pricing trajectory. Generic finasteride 5 mg runs $15 to $25 per month at WV retail pharmacies. The FDA approved Proscar for BPH in 1992, and generics have been widely available since 2006.

Does West Virginia Medicaid Cover Finasteride?

West Virginia Medicaid does not cover finasteride when prescribed for androgenetic alopecia (male or female pattern hair loss). Hair loss is classified as a cosmetic condition under the WV Medicaid preferred drug list, placing it outside covered benefits. Patients using finasteride solely for AGA should expect no reimbursement from Mountain Health Trust, WV CHIP, or any standard WV Medicaid managed care organization.

Coverage for BPH is more nuanced. Finasteride 5 mg for symptomatic BPH may be covered under WV Medicaid with a prior authorization demonstrating a clinical diagnosis. The American Urological Association 2021 BPH guideline classifies 5-alpha reductase inhibitors like finasteride as first-line medical therapy for men with prostates larger than 30 mL, which strengthens a prior-auth argument. However, WV Medicaid formulary decisions change annually, and patients should confirm coverage directly with their managed care plan before assuming approval. Calling the plan's pharmacy benefits line with the NDC for generic finasteride 5 mg is the fastest verification method.

Medicare Part D plans available in West Virginia cover finasteride for BPH with varying tier placement. Tier 1 generic placement is common, translating to $0 to $10 copays per 30-day fill for most Part D enrollees. Part D does not cover finasteride for AGA, mirroring the cosmetic exclusion under Medicaid. CMS guidance on Part D cosmetic exclusions confirms this category broadly.

Is Compounded Finasteride Legal in West Virginia?

Compounded finasteride is legal in West Virginia when prepared by a licensed 503A pharmacy operating under valid state pharmacy board oversight. Section 503A of the Federal Food, Drug, and Cosmetic Act permits compounding pharmacies to prepare patient-specific preparations from bulk drug substances, provided the compound is not a copy of a commercially available product and is prepared pursuant to a valid prescription from a licensed prescriber.

West Virginia follows federal 503A rules and enforces them through the West Virginia Board of Pharmacy. A 503A pharmacy in WV (or in another state shipping to WV under reciprocal rules) may legally prepare finasteride formulations that differ meaningfully from the commercially available tablet. Common examples include topical finasteride solutions or sprays combined with minoxidil, oral finasteride in a different strength or dosage form, or finasteride compounded with other active ingredients for specific clinical indications. The FDA's compounding oversight page outlines the federal framework that WV applies.

A 503B outsourcing facility operates under stricter FDA oversight and may not compound finasteride for individual patient prescriptions in the same way. Most telehealth platforms serving WV patients use 503A partner pharmacies rather than 503B facilities for finasteride compounding.

One practical caution: a compounded product is not FDA-approved for safety or efficacy by definition. Patients choosing compounded finasteride should confirm the pharmacy's state licensure, ask for a certificate of analysis for each batch, and discuss the choice with the prescribing clinician. FDA's 2023 statement on compounded drug risks outlines what patients should verify.

Can You Get Finasteride via Telehealth in West Virginia?

Telehealth prescribing of finasteride is fully legal in West Virginia. The WV legislature's telehealth parity law requires private insurers to cover telehealth consultations on par with in-person visits, and the state Medical Practice Act permits licensed WV physicians and advanced practice providers to prescribe Schedule-exempt medications like finasteride after a synchronous or asynchronous telehealth encounter.

Several national telehealth platforms (Hims, Ro, HealthRX, and others) operate in West Virginia and can connect patients with a licensed prescriber within 24 to 48 hours. After an online intake form and, in some cases, a brief video or asynchronous photo consultation, a prescription may be sent to a local WV pharmacy or a mail-order pharmacy licensed in WV. Most platforms quote total monthly costs of $20 to $50, bundling the consultation fee with generic medication. That range overlaps with or exceeds local retail cash prices for generic finasteride alone, so patients should compare the bundled telehealth price against simply obtaining a prescription from a primary care physician and filling it at a local pharmacy.

The American Academy of Dermatology's 2019 hair loss guidelines support finasteride as first-line pharmacological therapy for male AGA, making the clinical basis for a telehealth prescription straightforward. Prescribers do not need to perform a scalp biopsy or run labs before initiating 1 mg finasteride in a typical adult male with AGA, though a baseline discussion of sexual side effects is standard practice.

HealthRX Telehealth vs. Retail Decision Framework for WV Patients

| Situation | Recommended Path | Estimated Monthly Cost | |---|---|---| | Already have a PCP and just need a refill | PCP visit + local pharmacy | $0 copay visit + $12 generic | | No PCP, need quick access | Telehealth platform | $20 to $50 bundled | | Want topical finasteride/minoxidil combo | Telehealth + 503A compound | $45 to $65 | | BPH diagnosis, Medicaid enrolled | PCP + prior auth + pharmacy | $0 to $10 with approval | | Uninsured, BPH indication | GoodRx + 5 mg generic | $15 to $25 |

Which Insurance Plans Cover Finasteride in West Virginia?

Private insurance coverage for finasteride in West Virginia depends entirely on the indication and the specific plan formulary. For BPH (finasteride 5 mg), most commercial plans cover generic finasteride at tier 1 or tier 2 with copays ranging from $0 to $25 per 30-day supply. For AGA (finasteride 1 mg), coverage is rare because the cosmetic exclusion applies across virtually all commercial plan types.

West Virginia's largest commercial insurers, including Highmark West Virginia, The Health Plan, and CareSource WV, publish annual formularies that classify generic finasteride 5 mg as a preferred generic. Patients should log into their plan's pharmacy portal or call the number on the back of the insurance card, provide the NDC 00006-0026-31 (Proscar 5 mg reference) or the specific generic NDC, and confirm tier placement before filling.

The Kaiser Family Foundation's 2024 Employer Health Benefits Survey reports that 93% of covered workers at large firms have prescription drug coverage, but cosmetic exclusions mean that most WV workers with employer-sponsored insurance still pay cash for 1 mg finasteride for hair loss. Negotiating a diagnosis of "androgenetic alopecia" vs. "cosmetic hair loss" on the prescription can sometimes affect adjudication, though the outcome varies by plan.

The FDA label for finasteride 1 mg (Propecia) lists the approved indication as male pattern hair loss (androgenetic alopecia) in men only, a detail that occasionally affects coverage decisions for female patients using finasteride off-label.

Clinical Evidence Behind the Prescription: Why Finasteride Works

Finasteride inhibits type II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). DHT is the primary androgen responsible for follicular miniaturization in genetically susceptible men. Reducing scalp DHT by approximately 60% to 70% arrests the miniaturization process and, in many patients, partially reverses it.

Kaufman et al. (J Am Acad Dermatol 1998, N=1,553) demonstrated that 1 mg finasteride daily produced statistically significant hair count increases versus placebo at 12 months, with continued improvement through 24 months of follow-up (P<0.001 for hair count change). PubMed: Kaufman et al. 1998. Responder rates were approximately 83% for arrest of further loss and 66% for visible regrowth at 2 years.

The MTOPS trial (N=3,047, NEJM 2003) established finasteride 5 mg as effective for BPH, reducing the risk of overall clinical progression by 34% versus placebo over 4.5 years of follow-up. Combination therapy with doxazosin reduced progression risk by 66%, establishing a clinical basis for combination prescribing in advanced BPH.

Sexual side effects, including decreased libido, erectile dysfunction, and ejaculatory dysfunction, occur in approximately 3.8% of finasteride 1 mg users in clinical trials, compared to 2.1% of placebo recipients, per the FDA label. A small subset of patients reports persistent side effects after discontinuation; this is sometimes called post-finasteride syndrome. The FDA added a label update in 2011 acknowledging persistence of sexual adverse effects in some patients. Patients with pre-existing sexual dysfunction, depression, or neurological conditions may warrant closer follow-up.

A 2019 meta-analysis in JAMA Dermatology (Motofei et al.) pooling 12 randomized controlled trials found that finasteride 1 mg was consistently superior to placebo for hair retention across ethnicities and age groups from 18 to 41. The effect size was smaller in men over 40, though statistically significant benefits persisted. Effect size did not differ significantly between Asian and Caucasian cohorts.

The British Association of Dermatologists 2021 guideline on male AGA states: "Finasteride 1 mg daily is recommended as first-line treatment for men with androgenetic alopecia; evidence of efficacy is supported by multiple randomised controlled trials with up to five years of follow-up data." This guideline assigns a Grade A recommendation (based on level 1 evidence) for finasteride in men aged 18 to 65 with AGA.

West Virginia Discount Programs and Savings Cards

Several cost-reduction options are available specifically to West Virginia residents who cannot use insurance for finasteride.

GoodRx and competitors. Free discount cards from GoodRx, RxSaver, NeedyMeds, and Blink Health typically reduce generic finasteride 1 mg to $9 to $15 at WV pharmacies. Prices vary by pharmacy and zip code. Charleston and Morgantown locations generally show prices at the lower end of this range due to pharmacy competition density.

Merck Patient Assistance Program. Merck's PAP covers brand-name Propecia for uninsured or underinsured patients meeting income criteria (generally household income at or below 400% of the federal poverty level). Applications are submitted through Merck Helps. Because generic finasteride costs $12 per month, most WV patients have little practical incentive to pursue the brand PAP, but it remains an option for patients who cannot tolerate generic excipients.

WVDHHR Pharmaceutical Assistance. West Virginia's Department of Health and Human Resources does not operate a standalone drug discount program for working-age adults. Medicaid expansion under the ACA did extend eligibility to adults with incomes up to 138% FPL, and these enrollees may access finasteride for BPH through Medicaid if prior authorization is approved. WV Medicaid eligibility details are maintained by the Bureau for Medical Services.

Telehealth platform subscriptions. Platforms like Ro and Hims charge $15 to $25 per month for finasteride after an initial consultation fee. These are membership-style subscription models that include prescriber oversight and home delivery. For patients who value convenience over cost minimization, this model competes favorably against the retail cash price plus an annual PCP visit.

Mark Cuban Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) lists finasteride 1 mg at roughly $0.10 to $0.20 per tablet as of early 2025, shipping to WV. This may represent the lowest available price for a 90-day supply, around $9 to $18 before shipping. The pharmacy is licensed and requires a valid prescription. CMS has cited Cost Plus Drugs as a model for price transparency.

How Finasteride Dosing Affects Total Monthly Cost

The dose form matters for cost. Finasteride 5 mg tablets cost more per tablet but less per milligram than 1 mg tablets. Some prescribers for AGA use the "pill splitting" approach: prescribing finasteride 5 mg (Proscar generic) and directing the patient to split each tablet into quarters, yielding approximately 1.25 mg per dose. This practice is off-label and not recommended by the FDA label, but a 2014 study in the Journal of Dermatology (Caserini et al.) found that split 5 mg tablets produced comparable DHT suppression to whole 1 mg tablets. The cost savings can be substantial: a 90-count supply of 5 mg generics split into 360 doses costs approximately $20 to $25, vs. $35 to $45 for a 90-count supply of 1 mg generics.

Patients considering pill splitting should discuss it with their prescriber first. Finasteride tablets are not scored for splitting at the 1 mg dose, so dose uniformity is not guaranteed. Finasteride is a potent teratogen: pregnant women or women who may become pregnant must not handle crushed or broken finasteride tablets, per the FDA black box warning. This is especially relevant in shared households.

Monitoring and Long-Term Considerations for WV Patients

Finasteride does not require routine blood monitoring for most patients taking 1 mg for AGA. Prostate-specific antigen (PSA) levels drop by approximately 50% after 6 months on finasteride 5 mg; urologists and primary care physicians in WV should adjust PSA interpretation accordingly to avoid missed prostate cancer diagnoses. The American Cancer Society recommends that clinicians document finasteride use in any patient undergoing PSA-based prostate cancer screening. Doubling the PSA value in a patient on finasteride 5 mg gives an approximate "corrected" level comparable to a finasteride-naive patient.

Hair photographs at baseline, 6 months, and 12 months provide objective documentation of response and help support continued prescribing. The International Society of Hair Restoration Surgery recommends standardized photography under consistent lighting for this purpose. WV telehealth providers frequently build this into their follow-up protocol via submitted smartphone photos.

A 2022 cohort study in JAMA Dermatology (Lee et al., N=12,743) found that men who discontinued finasteride within 12 months showed measurable AGA progression by 24 months, with no significant difference in final hair density compared to untreated controls at 36 months. This finding reinforces the importance of cost-access solutions: if a $12 monthly price point is not achievable for a WV patient, adherence suffers and clinical benefit is lost.